Piramal Pharma Limited

NSEI:PPLPHARMA Stock Report

Market Cap: ₹326.0b

Piramal Pharma Dividends and Buybacks

Dividend criteria checks 0/6

Piramal Pharma is a dividend paying company with a current yield of 0.045%.

Key information

0.04%

Dividend yield

-3.2%

Buyback Yield

Total Shareholder Yield-3.2%
Future Dividend Yield0.4%
Dividend Growth117.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₹0.110
Payout ratio79%

Recent dividend and buyback updates

Recent updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Jul 14
Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Jun 17
Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

May 21
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Mar 26
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Feb 28
Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Feb 02
Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Nov 09
Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Aug 11
Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: PPLPHARMA is not paying a notable dividend for the Indian market, therefore no need to check if payments are stable.

Growing Dividend: PPLPHARMA is not paying a notable dividend for the Indian market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Piramal Pharma Dividend Yield vs Market
How does PPLPHARMA dividend yield compare to the market?
SegmentDividend Yield
Company (PPLPHARMA)0.04%
Market Bottom 25% (IN)0.3%
Market Top 25% (IN)1.1%
Industry Average (Pharmaceuticals)0.7%
Analyst forecast (PPLPHARMA) (up to 3 years)0.4%

Notable Dividend: PPLPHARMA's dividend (0.045%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.25%).

High Dividend: PPLPHARMA's dividend (0.045%) is low compared to the top 25% of dividend payers in the Indian market (1.14%).


Earnings Payout to Shareholders

Earnings Coverage: PPLPHARMA is not paying a notable dividend for the Indian market.


Cash Payout to Shareholders

Cash Flow Coverage: PPLPHARMA is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies